Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate versus propofol for sedation/anesthesia in hysteroscopy
ChiCTR2000033726Phase 4Recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- May 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of remimazolam, propofol and sufentanil (4 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Number of remedial cases, Failure rate and 1 more. Started May 2020; status: recruiting.
02
Drugs
remimazolampropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2000033726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033726.